Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of July 2018 (Filed July 23, 2018)
Context: This filing serves as a conduit for an ASX Announcement regarding the adoption of new reporting segments effective June 2018. The document primarily contains forward-looking statement disclosures and an exhibit index rather than detailed financial results for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing referencing an external announcement (Exhibit 99.1) regarding segment restructuring rather than a financial results report.
Material Changes
- Reporting Segments: The company announced new reporting segments effective June 2018, as detailed in the attached ASX Announcement (Exhibit 99.1).
- Operational Context: The filing references the integration of Fermacell into the business as a relevant factor for future operations.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing extensively lists factors that could cause future results to differ from expectations, including:
- Asbestos Liabilities: Risks related to the Asbestos Injuries Compensation Fund (AICF), including contribution shortfalls and currency exchange impacts on recorded liabilities.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Legal and Regulatory: Exposure to product liability, environmental claims, and tax law changes.
- Operational Risks: Raw material costs, competition, and the ability to renew credit facilities.
Management Commentary: The company explicitly states it assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (ASX Announcement) to understand the specific details of the new reporting segments implemented in June 2018.
- Verify the impact of the Fermacell integration on future financial performance and segment reporting.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and potential changes to contribution estimates.
- Check subsequent filings for detailed financial metrics, as this Form 6-K does not contain numerical results.